Alzheimer’s Drug Discovery Foundation Invests in First-of-its-Kind Biomarker Observatory Led by Renowned Clinical Trials Expert to Accelerate Novel Drug Development

Alzheimer’s Drug Discovery Foundation Invests in First-of-its-Kind Biomarker Observatory Led by Renowned Clinical Trials Expert to Accelerate Novel Drug Development The Alzheimer’s Drug Discovery Foundation (ADDF) has recently announced a groundbreaking investment aimed at revolutionizing the landscape of Alzheimer’s research and drug development. This investment is directed towards the creation of a first-of-its-kind biomarker observatory, […]

ADDF Marks Tenth Anniversary of Melvin R. Goodes Prize with Celebration in Stockholm, Sweden, Honoring Scientists Dedicated to Innovation in Alzheimer’s Research

ADDF Marks Tenth Anniversary of Melvin R. Goodes Prize with Celebration in Stockholm, Sweden, Honoring Scientists Dedicated to Innovation in Alzheimer’s Research The Alzheimer’s Drug Discovery Foundation (ADDF) recently celebrated a significant milestone in the fight against Alzheimer’s disease by hosting the tenth annual Melvin R. Goodes Prize event in Stockholm, Sweden. The event, which […]